mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |